{
    "title": "Sanofi and Regeneron's Dupixent meets endpoints in clinical trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11893337/Sanofi-Regenerons-Dupixent-meets-endpoints-clinical-trial.html",
    "date": "2023-03-23",
    "keywords": [
        "dupixent",
        "disease",
        "trial",
        "safety",
        "atopic",
        "dermatitis",
        "copd",
        "respiratory",
        "lung",
        "function",
        "phase",
        "placebo",
        "ec",
        "march",
        "product",
        "reduction",
        "decline",
        "quality",
        "life",
        "thursday",
        "profile",
        "efficacy",
        "tuesday",
        "commission",
        "union",
        "therapy",
        "esophagitis",
        "condition",
        "esophagus",
        "reporting",
        "juby",
        "babu",
        "bengaluru",
        "editing",
        "rashmi",
        "aich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}